Takuma Isshiki Selected Research

Takuma Isshiki Research Topics

Disease

11	Idiopathic Pulmonary Fibrosis 12/2023 - 01/2015
5	Interstitial Lung Diseases (Interstitial Lung Disease) 12/2023 - 01/2018
4	Sarcoidosis (Schaumann Disease) 08/2021 - 01/2013
3	Fibrosis (Cirrhosis) 01/2023 - 12/2017
3	Neoplasms (Cancer) 01/2020 - 12/2017
3	Inflammation (Inflammations) 05/2019 - 01/2015
2	Lung Diseases (Lung Disease) 12/2023 - 11/2020
2	Trichosporonosis 09/2023 - 11/2020
2	Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis) 09/2023 - 11/2020
2	Lung Neoplasms (Lung Cancer) 07/2021 - 01/2020
2	Pneumonia (Pneumonitis) 12/2017 - 08/2015
1	Disease Progression 12/2023
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 10/2023
1	Systemic Vasculitis 10/2023
1	Microscopic Polyangiitis 10/2023
1	Wounds and Injuries (Trauma) 01/2022
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2021
1	Circulating Neoplastic Cells 07/2021
1	Pulmonary Sarcoidosis 11/2020
1	Adenocarcinoma of Lung 01/2020
1	Rheumatoid Arthritis 05/2019
1	Thymoma (Thymic Carcinoma) 09/2018
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2018
1	Bronchiectasis 02/2018
1	Acute Lung Injury 01/2018
1	Hypoxia (Hypoxemia) 11/2017
1	Multiple Endocrine Neoplasia Type 2a (MEN 2) 01/2017

Drug/Important Bio-Agent (IBA)

4	ThrombomodulinIBA 05/2019 - 01/2015
3	Antifibrotic AgentsIBA 12/2023 - 02/2018
3	Proteins (Proteins, Gene)FDA Link 05/2019 - 01/2015
2	ErbB Receptors (EGF Receptor)IBA 07/2021 - 01/2020
2	PeriostinIBA 05/2021 - 11/2020
2	pirfenidoneIBA 03/2021 - 01/2017
1	Connective Tissue Growth FactorIBA 12/2023
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 10/2023
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2023
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2023
1	MicroRNAs (MicroRNA)IBA 01/2022
1	CollagenIBA 01/2022
1	Collagen Type I (Type I Collagen)IBA 01/2022
1	Formaldehyde (Formol)FDA Link 08/2021
1	Monoclonal AntibodiesIBA 08/2021
1	ParaffinIBA 08/2021
1	osimertinibIBA 07/2021
1	Messenger RNA (mRNA)IBA 07/2021
1	CC ChemokinesIBA 11/2020
1	Biomarkers (Surrogate Marker)IBA 11/2020
1	Matrix Metalloproteinase 7 (Matrilysin)IBA 11/2020
1	LigandsIBA 11/2020
1	Phosphotransferases (Kinase)IBA 01/2020
1	InterleukinsIBA 01/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Gefitinib (Iressa)FDA Link 01/2020
1	Thrombin FDA Link 05/2019
1	Complement System Proteins (Complement)IBA 05/2019
1	Etanercept (Enbrel)FDA Link 05/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2019
1	B7-H1 AntigenIBA 09/2018
1	pembrolizumabIBA 09/2018
1	HMGB1 Protein (HMG1)IBA 01/2018
1	Immune Checkpoint InhibitorsIBA 12/2017
1	Bleomycin (Blenoxane)FDA LinkGeneric 12/2017
1	Immunoglobulin G (IgG)IBA 12/2017
1	Interleukin-13IBA 08/2015
1	Cysteine Proteases (Cysteine Protease)IBA 08/2015
1	CytokinesIBA 08/2015
1	Interleukin-5 (Interleukin 5)IBA 08/2015
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2013
1	Methotrexate (Mexate)FDA LinkGeneric 01/2013
1	Cytotoxins (Cytolysins)IBA 01/2013

Therapy/Procedure

3	Therapeutics 01/2020 - 09/2018
2	Humidifiers 09/2023 - 11/2020
1	Drug Therapy (Chemotherapy) 09/2018
1	Traction 02/2018
1	Immunotherapy 12/2017
1	Activities of Daily Living (ADL) 11/2017
1	Aftercare (After-Treatment) 11/2017